Repligen Corporation News
10 must-know biotech stock events to close out 2016
Important clinical trial results in Alzheimer's, cancer and Crohn's disease and a big FDA decision for Sarepta are expected before the end of the year.
Trade-Ideas: Repligen (RGEN) Is Today's Weak On High Relative Volume Stock
Trade-Ideas LLC identified Repligen (RGEN) as a weak on high relative volume candidate
Today's Dead Cat Bounce Stock Is Repligen (RGEN)
Trade-Ideas LLC identified Repligen (RGEN) as a "dead cat bounce" (down big yesterday but up big today) candidate
Insider Trading Alert - RGEN, DVA And FLT Traded By Insiders
Stocks with insider trader activity include RGEN, DVA and FLT
Trade-Ideas: Repligen (RGEN) Is Today's New Lifetime High Stock
Trade-Ideas LLC identified Repligen (RGEN) as a new lifetime high candidate
GameStop Declares 4-for-1 Stock Split
GameStop's board declared a 4-for-1 stock split.
Elon Musk Can't Wait to See Disney Lose an Iconic Character
The billionaire CEO of Tesla, Elon Musk, strongly supports limiting the rights protecting certain original works.
Alphabet Stock Is Setting Up for a Trade Ahead of Stock Split
Alphabet stock has an interesting setup before the tech giant splits the shares. Here's the trade to know.
Microsoft Supports Abortion Access But Is Silent on Data Privacy
The software giant hasn't said it will protect user data in wake of Supreme Court ruling overturning Roe.